DE60220699D1 - Tibolonformulierungen - Google Patents

Tibolonformulierungen

Info

Publication number
DE60220699D1
DE60220699D1 DE60220699T DE60220699T DE60220699D1 DE 60220699 D1 DE60220699 D1 DE 60220699D1 DE 60220699 T DE60220699 T DE 60220699T DE 60220699 T DE60220699 T DE 60220699T DE 60220699 D1 DE60220699 D1 DE 60220699D1
Authority
DE
Germany
Prior art keywords
alpha
relates
tibolonformulierungen
tibolone
pregn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60220699T
Other languages
English (en)
Other versions
DE60220699T2 (de
Inventor
Tom Brennan
Austin John Woolfe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norton Healthcare Ltd
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26246675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60220699(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0125061.2A external-priority patent/GB0125061D0/en
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Publication of DE60220699D1 publication Critical patent/DE60220699D1/de
Application granted granted Critical
Publication of DE60220699T2 publication Critical patent/DE60220699T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Ceramic Products (AREA)
  • Steroid Compounds (AREA)
  • Powder Metallurgy (AREA)
  • Saccharide Compounds (AREA)
DE60220699T 2001-10-18 2002-10-18 Tibolonformulierungen Expired - Lifetime DE60220699T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB0125061.2A GB0125061D0 (en) 2001-10-18 2001-10-18 Pharmaceutical composition
GB0125061 2001-10-18
US35012101P 2001-11-02 2001-11-02
US350121P 2001-11-02
PCT/US2002/033526 WO2003032924A2 (en) 2001-10-18 2002-10-18 Novel tibolone formulations

Publications (2)

Publication Number Publication Date
DE60220699D1 true DE60220699D1 (de) 2007-07-26
DE60220699T2 DE60220699T2 (de) 2008-03-06

Family

ID=26246675

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60220699T Expired - Lifetime DE60220699T2 (de) 2001-10-18 2002-10-18 Tibolonformulierungen

Country Status (10)

Country Link
EP (1) EP1444247B1 (de)
AT (1) ATE364619T1 (de)
AU (1) AU2002347973A1 (de)
CY (1) CY1106754T1 (de)
DE (1) DE60220699T2 (de)
DK (1) DK1444247T3 (de)
ES (1) ES2284946T3 (de)
MX (1) MXPA04003588A (de)
PT (1) PT1444247E (de)
WO (1) WO2003032924A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1499278T3 (pl) * 2003-05-23 2005-09-30 Msd Oss Bv Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
WO2005084682A1 (en) * 2004-03-08 2005-09-15 Pharmaceutical Services Inc. (Psi Nv.) Pharmaceutical composition comprising cyclodextrin complex of tibolone
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
AU2017260799B2 (en) 2016-05-04 2022-11-24 Novalon S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
ZA941464B (en) * 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative

Also Published As

Publication number Publication date
WO2003032924A2 (en) 2003-04-24
EP1444247A2 (de) 2004-08-11
ES2284946T3 (es) 2007-11-16
DK1444247T3 (da) 2007-09-24
ATE364619T1 (de) 2007-07-15
AU2002347973A1 (en) 2003-04-28
EP1444247A4 (de) 2004-12-08
CY1106754T1 (el) 2012-05-23
WO2003032924A3 (en) 2004-01-29
DE60220699T2 (de) 2008-03-06
EP1444247B1 (de) 2007-06-13
PT1444247E (pt) 2007-07-09
MXPA04003588A (es) 2005-04-11

Similar Documents

Publication Publication Date Title
MXPA03010909A (es) Derivados de epotilona.
MXPA04008772A (es) Composiciones de clorhidrato de naltrexona.
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
BR0215405A (pt) Composições e processos de uso de collajolie
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
HK1058934A1 (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
DK1200418T3 (da) Nematodicide trifluorbutener
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
ATE330017T1 (de) Kallikrein gen
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
SE9903290D0 (sv) Novel compounds
MXPA03011128A (es) Composicion de sabor y fragancia.
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
BR0012751A (pt) Benzofuranos serotonérgicos
DE60220699D1 (de) Tibolonformulierungen
SE9904128D0 (sv) Novel compounds
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
MXPA03010821A (es) Composiciones de aroma y fragancias.
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas
PL365687A1 (en) Novel trioxepan compounds
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα
ATE480522T1 (de) 9-alkylamino-1-nitroacridin-derivate
ECSP003412A (es) Derivados de 3- amino -3-arilpropan - 1 - ol, su preparacion y su uso

Legal Events

Date Code Title Description
8364 No opposition during term of opposition